UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England. The new venture, Redx Anti-Infectives, will ...
Tags: Redx Pharma, Medicine
San Carlos, California, United States of America (Free-Press-Release.com) May 7, 2013 -- Rosa & Co. LLC today announced that Dr. Michael A. Eldon, Principal Scientific Fellow, VP, Clinical Pharmacology, Nektar Therapeutics, will present a ...
Nimbus Discovery, a US-based biotechnology company, has entered into a co-development agreement with Shire aiming at small molecule treatments for lysosomal storage disorders (LSDs), which are considered as the rare genetic diseases. The ...
FOR IMMEDIATE RELEASE San Carlos, California, United States of America (Free-Press-Release.com) May 9, 2013 -- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that ...
Tags: Construction, Decoration
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases. The funding will move the early-stage research to ...
Tags: Glaxosmithkline, funding injection
Inventiva and Novalix have entered into a strategic alliance to discover the clinical candidates, targeting nuclear receptors. As part of the agreement, Inventiva and NovAliX offer pharmaceutical and biotech companies a set of fully ...
Tags: NovAliX, clinical candidates
Corning Incorporated (NYSE: GLW) announced today an accounting change relating to expense recognition for company-sponsored pension plans. The new method, adopted in the first quarter of 2013, will result in simpler, more transparent ...
Tags: Construction, Corning
Proteros biostructures has collaborated with Priaxon to develop lead compounds for high value protein-protein interaction (PPI) drug targets. The combination of Proteros' structure guided discovery with Priaxon's PPI-directed drug ...
Tags: Proteros, Priaxon Collaborate, PPI Drug
Life Technologies has introduced two bioinformatics offerings, which will allow cancer researchers new avenues of access to one of the largest genomics databases available, compiled by the former Compendia Bioscience. Oncomine Gene ...
Tags: Life Technologies, Oncomine Bioinformatics Solutions, Cancer Researchers
KannaLife Sciences has partnered with Advanced Neural Dynamics and IteraMed for the discovery of new neuroprotectants. As part of the agreement, KannaLife will fund a new drug discovery project related to a laboratory validated ...
Tags: KannaLife Sciences, Neuroprotectants Discovery, Medicine
AG Mednet has signed the master services agreement with Biovisiq, a Japanese imaging core laboratory, (ICL) to provide zero-delay clinical trial solutions to Asian pharmaceutical market. The AG Mednet Submission Quality and Compliance ...
Why WestHolland? With almost 500 million residents, and a purchasing power second to none, Europe is one of the world's most important business and consumer markets. Dutch know-how and expertise in international trade and commerce make ...
Tags: Service, Business cooperation
US-based drug discovery and development service company Crown Bioscience and Horizon Discovery have entered into a two year collaboration agreement to provide combined solutions for in vivo model development. Under the partnership, ...
Certara, a US-based healthcare company, and ChemAxon, a provider of cheminformatics software platforms and desktop applications for the biotechnology and pharmaceutical industries, have signed a partnership agreement. The partnership will ...
Tags: healthcare company, healthcare, biotechnology, pharmaceutical industries
GlaxoSmithKline (GSK) is closing its Sirtris Pharmaceuticals office in Cambridge and fully integrating its research and development (R&D) operations with Philadelphia office. The firm is mulling to relocate some of the 60 staffers ...